SalvaRx Group PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.05 |
Market Cap |
GBP3.12 M |
Shares Outstanding |
36.7 M |
Public Float |
7.57 M |
Address |
Commerce House Ramsey Isle of Man IM8 2LQ United Kingdom |
Employees | - |
Website | http://www.salvarx.io |
Updated | 07/08/2019 |
SalvaRx Group Plc is a drug discovery and development company which focuses on immune-oncology. It invests in novel cancer immune-therapies and provides its portfolio companies with operational support ranging from direct operation of subsidiaries to advisory or part-time involvement in more established companies. The company was founded by Ian B. |